ATE244762T1 - Säugetier - expressionssysteme für hüllenprotingene des hepatitit - c - virus - Google Patents

Säugetier - expressionssysteme für hüllenprotingene des hepatitit - c - virus

Info

Publication number
ATE244762T1
ATE244762T1 AT95908700T AT95908700T ATE244762T1 AT E244762 T1 ATE244762 T1 AT E244762T1 AT 95908700 T AT95908700 T AT 95908700T AT 95908700 T AT95908700 T AT 95908700T AT E244762 T1 ATE244762 T1 AT E244762T1
Authority
AT
Austria
Prior art keywords
expression systems
protingenes
hepatitite
envelope
virus
Prior art date
Application number
AT95908700T
Other languages
English (en)
Inventor
Shinichi Watanabe
Julie Yamaguchi
Suresh M Desai
Sushil G Devare
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE244762T1 publication Critical patent/ATE244762T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
AT95908700T 1994-01-28 1995-01-27 Säugetier - expressionssysteme für hüllenprotingene des hepatitit - c - virus ATE244762T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/188,281 US5610009A (en) 1994-01-28 1994-01-28 Mammalian expression systems for hepatitis C virus envelope genes
PCT/US1995/001087 WO1995020664A2 (en) 1994-01-28 1995-01-27 Mammalian expression systems for hepatitis c virus envelope genes

Publications (1)

Publication Number Publication Date
ATE244762T1 true ATE244762T1 (de) 2003-07-15

Family

ID=22692507

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95908700T ATE244762T1 (de) 1994-01-28 1995-01-27 Säugetier - expressionssysteme für hüllenprotingene des hepatitit - c - virus

Country Status (9)

Country Link
US (1) US5610009A (de)
EP (1) EP0741787B1 (de)
JP (1) JPH09509052A (de)
AT (1) ATE244762T1 (de)
AU (1) AU1692595A (de)
CA (1) CA2182170A1 (de)
DE (1) DE69531235T2 (de)
ES (1) ES2207645T3 (de)
WO (1) WO1995020664A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040185061A1 (en) * 1994-07-29 2004-09-23 Innogenetics N.V. Redox reversible HCV proteins with native-like conformation
BR9506059A (pt) 1994-07-29 1997-10-28 Innogenetics Nv Proteinas envelopes purificadas de virus c para uso de diagnóstico e terapêutico
EP0836708A1 (de) * 1995-06-07 1998-04-22 Abbott Laboratories Nachwisverfahren für antikörper gegen das zweite hüllprotein des hepatitis c virus
US20050074752A1 (en) * 1996-06-11 2005-04-07 Merck & Co., Inc. Synthetic hepatitis C genes
AU717542B2 (en) * 1996-06-11 2000-03-30 Merck & Co., Inc. Synthetic hepatitis C genes
EP0947525A1 (de) 1998-03-27 1999-10-06 Innogenetics N.V. Epitope in der viralen Hüllproteine und spezifische Antikörper gegen diese Epitope: Verwendung für die detektion von viralantigene im empfängergewebe
AU4335099A (en) * 1998-06-18 2000-01-05 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Surface targeted expression of a modified hepatitis c virus envelope protein
US7108855B2 (en) * 1998-06-24 2006-09-19 Innogenetics N.V. Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
CA2389206C (en) * 1999-10-27 2011-01-04 Chiron Corporation Activation of hcv-specific t cells
US7101561B2 (en) 2000-12-01 2006-09-05 Innogenetics N.V. Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
US20030215896A1 (en) * 2001-04-25 2003-11-20 Yueming Li Gamma secretase substrates and in vitro assays
WO2002090572A2 (en) * 2001-05-09 2002-11-14 Third Wave Technologies, Inc. Nucleic acid detection in pooled samples
WO2003008541A2 (en) * 2001-07-16 2003-01-30 Eli Lilly And Company Extracellular junctional adhesion molecules
DK1558276T3 (da) * 2002-11-08 2012-10-22 Univ Tulane Flavivirus-fusionsinhibitorer
CN102614510A (zh) 2004-10-18 2012-08-01 全球免疫股份有限公司 基于酵母的对慢性丙型肝炎感染的治疗
AU2015234338C1 (en) * 2006-07-28 2017-07-20 The Trustees Of The University Of Pennsylvania Improved vaccines and methods for using the same
US20100286070A1 (en) * 2007-09-14 2010-11-11 Gert Verheyden Affinity tag

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5523215A (en) * 1985-03-28 1996-06-04 Chiron Corporation Enhanced purification and expression of insoluble recombinant proteins
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
NZ227011A (en) * 1987-11-18 1992-03-26 Chiron Corp Non-a, non-b-hepatitis (hepatitis c) antigens, proteins, nucleotide sequences, vaccines and kits
GB2212511B (en) * 1987-11-18 1992-01-22 Chiron Corp Hepatitis c virus
KR0185373B1 (ko) * 1989-03-17 1999-05-01 로버트 피. 블랙버언 Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
EP0842947B2 (de) * 1990-11-08 2009-03-18 Novartis Vaccines and Diagnostics, Inc. Asialoglykoproteine des Hepatitis C Virus
AU2513592A (en) * 1991-08-21 1993-03-16 Abbott Laboratories Hepatitis c assay utilizing recombinant antigens to ns1
EP0627000B1 (de) * 1992-01-31 2003-10-29 Abbott Laboratories Expressionssystem in säugetieren für hcv-proteine
JPH05344899A (ja) * 1992-06-11 1993-12-27 Kokuritsu Yobou Eisei Kenkyusho Ｃ型肝炎ウイルス外被タンパク質の産生法

Also Published As

Publication number Publication date
CA2182170A1 (en) 1995-08-03
EP0741787B1 (de) 2003-07-09
JPH09509052A (ja) 1997-09-16
AU1692595A (en) 1995-08-15
US5610009A (en) 1997-03-11
DE69531235T2 (de) 2004-05-13
WO1995020664A2 (en) 1995-08-03
ES2207645T3 (es) 2004-06-01
DE69531235D1 (de) 2003-08-14
EP0741787A1 (de) 1996-11-13
WO1995020664A3 (en) 1995-12-28

Similar Documents

Publication Publication Date Title
ATE244762T1 (de) Säugetier - expressionssysteme für hüllenprotingene des hepatitit - c - virus
CA2129733A1 (en) Mammalian expression systems for hcv proteins
AU600466B2 (en) Htlv-iii envelope peptides
AU5055593A (en) Antibodies specific for HIV
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
ES2188583T3 (es) Polipeptidos para el virus de la hepatitis c (hcv).
ES2130121T3 (es) Antigeno intra-acrosomico de esperma humano para uso en una vacuna anticonceptiva.
DK614987A (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
ATE314462T1 (de) Verfahren zur transformation dendritischer zellen und aktivierung von t zellen
AR022236A1 (es) Citoquinas mamiferas purificadas; reactivos y metodos relacionados
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
DK0480949T3 (da) Fremstilling af virus og oprensning af virale kappeproteiner til vaccineanvendelse
DK208987D0 (da) Polypeptider og antistoffer, som er karakteristiske for papillomvirus, og deres anvendelse ved diagnostiske metoder og i vacciner
DK0771213T3 (da) Haemophilus influenza adhærens- og penetrationsproteiner
AR022237A1 (es) Citoquinas mamiferas purificadas; reactivos y metodos relacionados
BR9713450A (pt) Quimiocinas de mamìfero
MY116208A (en) Improved hcv diagnostic agents
DE68923286D1 (de) Impfstoffe und testsätze für haemophilus influenzae.
WO1996012190A3 (en) Presentation of hydrophobic antigens to t-cells by cd1 molecules
PT1105155E (pt) Vacina compreendendo proteinas de choque termico (hsp) induzidas por citocina
AU8405798A (en) A swine hepatitis e virus and uses thereof
ATE294237T1 (de) S?ugetier thymokingene
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
FI870501L (fi) Menetelmä melanoomaan liittyvän p97-antigeenin antigeenisen sukulaispeptidin tai -proteiinin valmistamiseksi, sekä siinä käyttökelpoiset yhdistelmävirukset, yhdistelmävektorit ja isäntäsolut

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0741787

Country of ref document: EP

REN Ceased due to non-payment of the annual fee